ANGLE PLC

AGL

Company Profile

  • Business description

    ANGLE PLC is active in the healthcare sector in the United Kingdom. The Company's principal trading activity is undertaken in relation to the development and commercialization of the Parsortix cell separation system, with deployment in liquid biopsy that is non-invasive cancer diagnostics. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which the majority of its revenue is generated from Europe.

  • Contact

    10 Nugent Road
    The Surrey Research Park
    Surrey
    GuildfordGU2 7AF
    GBR

    T: +44 1483343434

    E: [email protected]

    https://www.angleplc.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    150

Stocks News & Analysis

stocks

Best and worst performing ASX sectors of 2024

Exploring the ASX sectors that moved the market this year.
stocks

2 ASX companies with the traits of a long-term winner

Two companies that show promising signs of handsomely rewarding shareholders.
video

Our outlook for 2025

Morningstar Equity Market Strategist Lochlan Halloway discusses his view on what we can expect in markets in 2025. 

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,465.0044.500.53%
CAC 407,393.7613.020.18%
DAX 4020,024.66115.520.58%
Dow JONES (US)42,417.35126.87-0.30%
FTSE 1008,260.0987.071.07%
HKSE19,623.32436.63-2.18%
NASDAQ19,264.9745.83-0.24%
Nikkei 22539,894.54386.62-0.96%
NZX 50 Index13,110.74159.27-1.20%
S&P 5005,867.4514.18-0.24%
S&P/ASX 2008,201.2042.100.52%
SSE Composite Index3,262.5689.20-2.66%

Market Movers